{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:50:32Z","timestamp":1785322232783,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008140","name":"The University of Chicago Pritzker School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008140","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.dadr.2025.100343","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T21:59:33Z","timestamp":1746741573000},"page":"100343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Access to and predictors of substance use treatment and support among people experiencing incarceration in the United States: Analysis of a national cross-sectional study"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-3964","authenticated-orcid":false,"given":"Samuel J.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold A.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4096-6822","authenticated-orcid":false,"given":"Elizabeth M.","family":"Salisbury-Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai T.","family":"Pho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15332640.2012.652516","article-title":"Racial and ethnic differences in substance abuse treatment initiation and engagement","volume":"11","author":"Acevedo","year":"2012","journal-title":"J. Ethn. Subst. Abus."},{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227966","article-title":"Socioeconomic risk factors for fatal opioid overdoses in the United States: findings from the mortality disparities in American Communities Study (MDAC)","volume":"15","author":"Altekruse","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.dadr.2025.100343_bib3","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"9","key":"10.1016\/j.dadr.2025.100343_bib4","article-title":"Factors associated with the availability of medications for opioid use disorder in US Jails","volume":"7","author":"Balawajder","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2025.100343_bib5","first-page":"2007","article-title":"Drug Use","author":"Bronson","year":"2017","journal-title":"Depend., Abus. State Prison. Jail Inmates"},{"issue":"13","key":"10.1016\/j.dadr.2025.100343_bib6","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1080\/10826084.2020.1795683","article-title":"Polysubstance use patterns among justice-involved individuals who use opioids","volume":"55","author":"Bunting","year":"2020","journal-title":"Subst. Use Misuse"},{"issue":"3\u20134","key":"10.1016\/j.dadr.2025.100343_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijlp.2013.04.003","article-title":"Predictors of retention in a drug-free unit\/substance abuse treatment in prison","volume":"36","author":"Casares-L\u00f3pez","year":"2013","journal-title":"Int. J. Law Psychiatry"},{"key":"10.1016\/j.dadr.2025.100343_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109291","article-title":"Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic","volume":"232","author":"Dadiomov","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"5, 2022","key":"10.1016\/j.dadr.2025.100343_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-criminol-011518-024445","article-title":"The failed regulation and oversight of American Prisons","volume":"5","author":"Dolovich","year":"2022","journal-title":"Annu. Rev. Criminol."},{"issue":"9","key":"10.1016\/j.dadr.2025.100343_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.2807","article-title":"Disparities in medication use for criminal justice system\u2013referred opioid use disorder treatment","volume":"5","author":"Donahoe","year":"2024","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.dadr.2025.100343_bib11","unstructured":"Drug Overdoses\u2014Data Details. 2024. National Safety Council Injury Facts. Retrieved December 11, 2024, from \u3008https:\/\/injuryfacts.nsc.org\/home-and-community\/safety-topics\/drugoverdoses\/data-details\/\u3009"},{"key":"10.1016\/j.dadr.2025.100343_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109254","article-title":"Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder","volume":"231","author":"Evans","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.dadr.2025.100343_bib13","first-page":"1453","article-title":"Challenge of prison oversight","volume":"47","author":"Fathi","year":"2010","journal-title":"Am. Crim. Law Rev."},{"key":"10.1016\/j.dadr.2025.100343_bib14","first-page":"20934","article-title":"Provision of health care services related to substance use disorder in southern US jails","volume":"158","author":"Fortino","year":"2024","journal-title":"J. Subst. Use Addict. Treat."},{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Subst. Abus."},{"issue":"2S","key":"10.1016\/j.dadr.2025.100343_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1353\/hpu.2017.0057","article-title":"Substance use disorders and related health problems in an aging offender population","volume":"28","author":"Gates","year":"2017","journal-title":"J. Health Care Poor Under"},{"key":"10.1016\/j.dadr.2025.100343_bib17","unstructured":"Glaze, L. 2019. Methodology: Survey of Prison Inmates, 2016. Bureau of Justice Statistics. \u3008https:\/\/bjs.ojp.gov\/content\/pub\/pdf\/mspi16.pdf\u3009"},{"key":"10.1016\/j.dadr.2025.100343_bib18","series-title":"U.S. overdose deaths remain higher than in other countries \u2013 trend tracking and harm-reduction policies could help","author":"Gumas","year":"2025"},{"issue":"9","key":"10.1016\/j.dadr.2025.100343_bib19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/0093854819846528","article-title":"Substance use disorder treatment in the reentry environment: service receipt and prisoner community reintegration","volume":"46","author":"Hamilton","year":"2019","journal-title":"Crim. Justice Behav."},{"key":"10.1016\/j.dadr.2025.100343_bib20","article-title":"Fatal and nonfatal opioid overdose risk following release from prison: a retrospective cohort study using linked administrative data","volume":"147","author":"Hartung","year":"2023","journal-title":"J. Subst. Use Addict. Treat."},{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1094670515593914","article-title":"Antiservice as guiding maxim: tough lessons from a maximum security prison","volume":"19","author":"Hill","year":"2016","journal-title":"J. Serv. Res."},{"key":"10.1016\/j.dadr.2025.100343_bib22","unstructured":"Homans, M., Allen, D.M., & Mazariegos, Y. 2023. A Review of Medication Assisted Treatment (MAT) in United States Jails and Prisons. Center for Evidence-Based Corrections."},{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","article-title":"A conceptual model for understanding post-release opioid-related overdose risk","volume":"14","author":"Joudrey","year":"2019","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"7","key":"10.1016\/j.dadr.2025.100343_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10654-007-9134-1","article-title":"Factors associated with mortality in a cohort of Australian prisoners","volume":"22","author":"Kariminia","year":"2007","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/add.15580","article-title":"Prevalence of co-occurring mental illness and substance use disorder and association with overdose: a linked data cohort study among residents of British Columbia, Canada","volume":"117","author":"Keen","year":"2022","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.dadr.2025.100343_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/23774657.2017.1399095","article-title":"The impact of prison programming on recidivism","volume":"4","author":"Lee","year":"2019","journal-title":"Corrections"},{"issue":"6","key":"10.1016\/j.dadr.2025.100343_bib27","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.dadr.2025.100343_bib28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1891\/0886-6708.VV-D-13-00137","article-title":"Violent death rates and risk for released prisoners in North Carolina","volume":"30","author":"Lize","year":"2015","journal-title":"Violence Vict."},{"key":"10.1016\/j.dadr.2025.100343_bib29","unstructured":"Longley, J. 2024. Litigation Approaches to Expanding Access to Medications for Opioid Use Disorder. Opioid Principles. \u3008https:\/\/opioidprinciples.jhsph.edu\/litigation-approaches-medications-for-opioid-use-disorder\/\u3009"},{"key":"10.1016\/j.dadr.2025.100343_bib30","unstructured":"Longley, J., Weizman, S., Brown, S., & LaBelle, R. 2023. Access to Medications for Opioid Use Disorder in US Jails and Prisons: A National Snaphot Update. O\u2019Neill Institute at Georgetown Law. \u3008https:\/\/oneill.law.georgetown.edu\/publications\/a-national-snapshot-update-access-to-medications-for-opioid-use-disorder-in-u-s-jails-and-prisons\/\u3009"},{"issue":"7","key":"10.1016\/j.dadr.2025.100343_bib31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1176\/appi.ps.56.7.840","article-title":"Incarceration associated with homelessness, mental disorder, and co-occurring substance abuse","volume":"56","author":"McNiel","year":"2005","journal-title":"Psychiatr. Serv. (Wash., D. C. )"},{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00952990500328463","article-title":"Predictors of prison-based treatment outcomes: a comparison of men and women participants","volume":"32","author":"Messina","year":"2006","journal-title":"Am. J. Drug Alcohol Abus."},{"issue":"4","key":"10.1016\/j.dadr.2025.100343_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11292-007-9040-2","article-title":"Does incarceration-based drug treatment reduce recidivism? A meta-analytic synthesis of the research","volume":"3","author":"Mitchell","year":"2007","journal-title":"J. Exp. Criminol."},{"key":"10.1016\/j.dadr.2025.100343_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","article-title":"Effectiveness of medication assisted treatment for opioid use in prison and jail settings: a meta-analysis and systematic review","volume":"99","author":"Moore","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1353\/hpu.2022.0031","article-title":"Availability of health care services and medications for opioid use disorder in carceral facilities in Washington, Oregon, and Idaho","volume":"33","author":"Neill-Gubitz","year":"2022","journal-title":"J. Health Care Poor Under"},{"key":"10.1016\/j.dadr.2025.100343_bib36","unstructured":"Nellis, A. 2021. The Color of Justice: Racial and Ethnic Disparity in State Prisons. The Sentencing Project. \u3008https:\/\/www.sentencingproject.org\/reports\/the-color-of-justice-racial-and-ethnic-disparity-in-state-prisons-the-sentencing-project\/\u3009"},{"issue":"8","key":"10.1016\/j.dadr.2025.100343_bib37","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3390\/healthcare11081182","article-title":"Unemployment and substance use: an updated review of studies from North America and Europe","volume":"11","author":"Nolte-Troha","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.dadr.2025.100343_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addbeh.2014.09.005","article-title":"Race\/ethnic disparities in the utilization of treatment for drug dependent inmates in U.S. state correctional facilities","volume":"40","author":"Nowotny","year":"2015","journal-title":"Addict. Behav."},{"issue":"1\u20132","key":"10.1016\/j.dadr.2025.100343_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100343_bib40","article-title":"The association between attitudes and the provision of medications for opioid use disorder (MOUD) in United States jails","volume":"10","author":"Pfaff","year":"2023","journal-title":"Drug Alcohol Depend. Rep."},{"key":"10.1016\/j.dadr.2025.100343_bib41","first-page":"2024","article-title":"The public health community must stand up for greater resources devoted to criminal justice research","volume":"11","author":"Pollack","year":"2024","journal-title":"Milbank Meml. Fund. Retrieved"},{"issue":"9","key":"10.1016\/j.dadr.2025.100343_bib42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2105\/AJPH.2018.304514","article-title":"Opioid Overdose Mortality Among Former North Carolina Inmates: 2000\u20132015","volume":"108","author":"Ranapurwala","year":"2018","journal-title":"Am. J. Public Health"},{"issue":"9","key":"10.1016\/j.dadr.2025.100343_bib43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dadr.2025.100343_bib44","unstructured":"Sawyer, W. 2019. Since you asked: Is it me, or is the government releasing less data about the criminal justice system? Prison Policy Initiative. \u3008https:\/\/www.prisonpolicy.org\/blog\/2019\/11\/14\/criminal-justice-data\/\u3009"},{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40352-021-00143-9","article-title":"The impact of the opioid crisis on U.S. state prison systems","volume":"9","author":"Scott","year":"2021","journal-title":"Health Justice"},{"key":"10.1016\/j.dadr.2025.100343_bib46","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015\u20132016","volume":"67","author":"Seth","year":"2018","journal-title":"Mmwr. Morb. Mortal. Wkly. Rep."},{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2288-8-70","article-title":"Reducing bias through directed acyclic graphs","volume":"8","author":"Shrier","year":"2008","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.dadr.2025.100343_bib48","doi-asserted-by":"crossref","unstructured":"Spencer, M.R., Garnett, M.F., & Mini\u00f1o, A.M. 2024. Drug Overdose Deaths in the United States, 2002-2022. CDC.Gov. https:\/\/doi.org\/10.15620\/cdc:135849","DOI":"10.15620\/cdc:135849"},{"issue":"6","key":"10.1016\/j.dadr.2025.100343_bib49","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11606-022-07812-x","article-title":"Availability of medications for opioid use disorder in U.S. jails","volume":"38","author":"Sufrin","year":"2023","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.dadr.2025.100343_bib50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jsat.2006.12.019","article-title":"Drug treatment services for adult offenders: the state of the state","volume":"32","author":"Taxman","year":"2007","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.dadr.2025.100343_bib51","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/08897077.2022.2060448","article-title":"Medications for opioid use disorder in state prisons: perspectives of formerly incarcerated persons","volume":"43","author":"Treitler","year":"2022","journal-title":"Subst. Abus."},{"issue":"2","key":"10.1016\/j.dadr.2025.100343_bib52","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2025.100343_bib53","unstructured":"Weizman, S., El-Sabawi, T., Perez, J., Baney, M., & Manoff, I. 2021. National Snapshot: Access to Medications for Opioid Use Disorder in U.S. Jails and Prisons. O\u2019Neill Institute at Georgetown Law. \u3008https:\/\/oneill.law.georgetown.edu\/publications\/national-snapshot-access-to-medications-for-opioid-use-disorder-in-u-s-jails-and-prisons\/\u3009"},{"issue":"3","key":"10.1016\/j.dadr.2025.100343_bib54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2008.03.019","article-title":"Predictors of therapeutic engagement in prison-based drug treatment","volume":"96","author":"Welsh","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100343_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112585","article-title":"Association between homelessness and opioid overdose and opioid-related hospital admissions\/emergency department visits","volume":"242","author":"Yamamoto","year":"2019","journal-title":"Soc. Sci. Med."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T23:54:57Z","timestamp":1748994897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724625000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":55,"alternative-id":["S2772724625000265"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100343","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Access to and predictors of substance use treatment and support among people experiencing incarceration in the United States: Analysis of a national cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100343"}}